# Characterization of Interventricular Conduction Measurements

> **NCT01362465** · EARLY_PHASE1 · COMPLETED · sponsor: **Medtronic Cardiac Rhythm and Heart Failure** · enrollment: 25 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **PROCEDURE:** Cardiac Resynchronization Therapy

## Key facts

- **NCT ID:** NCT01362465
- **Lead sponsor:** Medtronic Cardiac Rhythm and Heart Failure
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2012-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01362465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01362465, "Characterization of Interventricular Conduction Measurements". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01362465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
